IR-News

AUSSENDER



Medigene AG
Ansprechpartner: Medigene PR/IR
Tel.: +49 89 2000 33 3301
E-Mail: investor@medigene.com
pta20180604030
Release according to article 40 para. 1 WpHG

Medigene AG: Release according to Article 40, Section 1 of the WpHG

Voting Rights Announcement

Planegg (pta030/04.06.2018/20:15) - Release of Voting Rights Announcement

Notification of Major Holdings

1. Details of issuer:
Medigene AG, Lochhamer Straße 11, 82152 Planegg, Germany

2. Reason for notification:
Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation
Name: TONGYANG Networks Co., Ltd.
City and country of registered office: Seoul, South Korea

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3


5. Date on which threshold was crossed or reached
25.05.2018

6. Total positions

% of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer
Resulting situation 3.70 3.70 22,314,595
Previous notification

7. Notified details of the resulting situation

a. Voting rights attached to shares (Sec.s 33, 34 WpHG)

ISIN absolute direct (Sec. 33 WpHG) absolute indirect (Sec. 34 WpHG) in % direct (Sec. 33 WpHG) in % indirect (Sec. 34 WpHG)
DE000A1X3W00 825,000 0 3.70 0.00
Total: 825,000 3.7

b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG

Type of instrument Maturity / Expiration Exercise or conversion period Voting Rights Absolute Voting Rights in %
Total:

b.2 Instruments according to Sec. 38 para. 1 No. 2 WpHG

Type of instrument Maturity / Expiration Exercise or conversion period Cash or physical transaction Voting Rights Absolute Voting Rights in %
Total:

8. Information in relation to the person subject to the notification obligation

Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).

Name % of voting rights if 3% or higher % of voting rights through instruments if 5% or higher Total of both if 5% or higher

9. In case of proxy voting according to § 34 para. 3 WpHG

Date of general meeting: N/A

10. Other useful information (end)

emitter: Medigene AG
Lochhamer Straße 11
82152 Planegg
Germany
contact person: Medigene PR/IR
phone: +49 89 2000 33 3301
e-mail: investor@medigene.com
website: www.medigene.de
stock exchanges: regulated market in Frankfurt; free market in Dusseldorf, free market in Hamburg, free market in Hannover, free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate
ISIN(s): DE000A1X3W00
|
|
98.207 Abonnenten
|
166.154 Meldungen
|
65.395 Pressefotos

BUSINESS

21.09.2018 - 11:30 | Travel Industry Club Austria
21.09.2018 - 09:30 | OPWZ - Österr. Produktivitäts- und Wirtschaftlichkeits-Zentrum
21.09.2018 - 09:15 | Möbel Polt GmbH & Co KG
21.09.2018 - 06:15 | pressetext.redaktion
20.09.2018 - 17:20 | Pädagogische Hochschule Niederösterreich
Top